![XBiotech Inc](/common/images/company/N_XBIT.png)
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Show more
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotechΒ (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...
AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- XBiotech Inc. today announced that it plans to expand itβs campus headquarters with the construction of a new, state-of-the-art research and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.22 | -4.2226487524 | 5.21 | 5.47 | 4.3901 | 164809 | 4.85975736 | CS |
4 | -2.55 | -33.8196286472 | 7.54 | 7.89 | 4.3901 | 123456 | 5.72450529 | CS |
12 | -3.54 | -41.5005861665 | 8.53 | 9.96 | 4.3901 | 97585 | 7.3996637 | CS |
26 | 1.09 | 27.9487179487 | 3.9 | 9.96 | 3.83 | 71695 | 7.00368512 | CS |
52 | -1.08 | -17.7924217463 | 6.07 | 9.96 | 3.51 | 45477 | 6.49593531 | CS |
156 | -12.23 | -71.0220673635 | 17.22 | 18.46 | 3 | 62678 | 7.87307673 | CS |
260 | -2.61 | -34.3421052632 | 7.6 | 33.2 | 3 | 137078 | 14.32609931 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.